With a history that stretches back to 1979 when TP53 was discovered, the TP53 pathway has received much attention in cancer biology and oncology with the pathway being a multifaceted, complex cellular stress response pathway with downstream effects that are pertinent to its function as a tumour suppressor route. The gene discussed is TP53; the disease is neoplasm.